M E O'Brien Selected Research

M E O'Brien Research Topics

3	Breast Neoplasms (Breast Cancer) 09/2001 - 01/2000
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2001 - 10/2000
2	Infections 05/2018 - 06/2000
2	Neoplasms (Cancer) 09/2001 - 01/2000
1	Aortic Dissection 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Postmenopausal Osteoporosis 09/2001
1	Small Cell Carcinoma 01/2001
1	Lung Neoplasms (Lung Cancer) 01/2001
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2000
1	Prostatic Neoplasms (Prostate Cancer) 10/2000
1	Inflammation (Inflammations) 10/2000
1	Melanoma (Melanoma, Malignant) 10/2000
1	Mesothelioma 10/2000
1	Agranulocytosis (Granulocytopenia) 06/2000
1	Disease Progression 06/2000
1	Sepsis (Septicemia) 06/2000
1	Thrombocytopenia (Thrombopenia) 06/2000
1	Diarrhea 06/2000
1	Inflammatory Breast Neoplasms 06/2000
1	Necrosis 01/2000

2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2001 - 01/2001
2	Vinblastine (Vinblastine Sulfate)FDA Link 03/2001 - 01/2001
1	esmolol (Brevibloc)FDA LinkGeneric 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2018
1	Estrogen ReceptorsIBA 09/2001
1	Raloxifene Hydrochloride (Evista)FDA Link 09/2001
1	Cisplatin (Platino)FDA LinkGeneric 03/2001
1	Carboplatin (JM8)FDA LinkGeneric 01/2001
1	AntibodiesIBA 12/2000
1	VaccinesIBA 10/2000
1	SRL172IBA 10/2000
1	eniluracilIBA 06/2000
1	Fluorouracil (Carac)FDA LinkGeneric 06/2000
1	Pharmaceutical PreparationsIBA 06/2000
1	Cytotoxins (Cytolysins)IBA 06/2000
1	Interleukin-2 (IL2)IBA 01/2000
1	Interleukin-4 (Interleukin 4)IBA 01/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2000
1	Interferon-gamma (Interferon, gamma)IBA 01/2000

6	Drug Therapy (Chemotherapy) 03/2001 - 01/2000
2	Therapeutics 01/2021 - 09/2001
2	Combination Drug Therapy (Combination Chemotherapy) 10/2000 - 06/2000
1	Aftercare (After-Treatment) 09/2001
1	Radiotherapy 01/2001
1	Injections 10/2000
1	Blood Transfusion (Blood Transfusions) 01/2000